Skip to main content
Top

31-10-2024 | Myelodysplastic Syndrome | CE - LETTER TO THE EDITOR

Eltrombopag treatment for thrombocytopenia in myelodysplastic syndromes: differences between responding and non-responding patients—a pilot study

Authors: Roberto Castelli, Roberto Manetti, Gemma Lisa Sechi, Giorgio Lambertenghi Deliliers, Antonio Gidaro

Published in: Internal and Emergency Medicine

Login to get access

Excerpt

Dear Sir, …
Literature
3.
go back to reference Giagounidis A, Mufti GJ, Fenaux P, Sekeres MA, Szer J, Platzbecker U et al (2014) Results of a randomized, double-blind study of romiplostim versus placebo in patients with low/intermediate-1-risk myelodysplastic syndrome and thrombocytopenia. Cancer 120(12):1838–1846. https://doi.org/10.1002/cncr.28663. (Epub 2014 Apr 4)CrossRefPubMed Giagounidis A, Mufti GJ, Fenaux P, Sekeres MA, Szer J, Platzbecker U et al (2014) Results of a randomized, double-blind study of romiplostim versus placebo in patients with low/intermediate-1-risk myelodysplastic syndrome and thrombocytopenia. Cancer 120(12):1838–1846. https://​doi.​org/​10.​1002/​cncr.​28663. (Epub 2014 Apr 4)CrossRefPubMed
4.
go back to reference Thiele J, Kvasnicka HM, Facchetti F, Franco V, van der Walt J, Orazi A (2005) European consensus on grading bone marrow fibrosis and assessment of cellularity. Haematologica 90(8):1128–1132PubMed Thiele J, Kvasnicka HM, Facchetti F, Franco V, van der Walt J, Orazi A (2005) European consensus on grading bone marrow fibrosis and assessment of cellularity. Haematologica 90(8):1128–1132PubMed
Metadata
Title
Eltrombopag treatment for thrombocytopenia in myelodysplastic syndromes: differences between responding and non-responding patients—a pilot study
Authors
Roberto Castelli
Roberto Manetti
Gemma Lisa Sechi
Giorgio Lambertenghi Deliliers
Antonio Gidaro
Publication date
31-10-2024
Publisher
Springer International Publishing
Published in
Internal and Emergency Medicine
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-024-03804-3

Keynote series | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the broader systemic effects of menopause, so you can help patients in your clinics through the transition.

Launching: Thursday 12th December 2024
 

Prof. Martha Hickey
Dr. Claudia Barth
Dr. Samar El Khoudary
Developed by: Springer Medicine
Register your interest now

Keynote webinar | Spotlight on adolescent vaping

  • Live
  • Webinar | 29-01-2025 | 18:00 (CET)

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?

Watch it live: Wednesday 29th January, 18:00-19:30 CET
 

Prof. Ann McNeill
Dr. Debbie Robson
Benji Horwell
Developed by: Springer Medicine
Join the webinar

Keynote webinar | Spotlight on modern management of frailty

Frailty has a significant impact on health and wellbeing, especially in older adults. Our experts explain the factors that contribute to the development of frailty and how you can manage the condition and reduce the risk of disability, dependency, and mortality in your patients.

Prof. Alfonso Cruz-Jentoft
Prof. Barbara C. van Munster
Prof. Mirko Petrovic
Developed by: Springer Medicine
Watch now

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more